Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Cell Mol Med ; 24(20): 11922-11935, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32869923

RESUMEN

Selaginella moellendorffii Hieron. (SM), a perennial evergreen plant, has been used in the treatment of acute infectious hepatitis, thoracic and hypochondriac lumbar contusions, systemic oedema and thrombocytopaenia. However, the role of a biflavonoid-rich extract from SM (SM-BFRE) in anti-larynx cancer has rarely been reported. In this study, the in vitro and in vivo anti-laryngeal cancer activity and potential mechanisms of SM-BFRE were investigated. An off-line semipreparative liquid chromatography-nuclear magnetic resonance protocol was carried out to determine six biflavonoids from SM-BFRE. In vitro, MTT assay revealed that SM-BFRE inhibited the proliferation of laryngeal carcinoma cells. A wound healing assay indicated that SM-BFRE suppressed the migration of laryngeal cancer cells. Hoechst 33 258 and Annexin V-FITC/PI double staining assays were performed and verified that SM-BFRE induced apoptosis in laryngeal carcinoma cells. The Hep-2 bearing nude mouse model confirmed that SM-BFRE also exhibited anticancer effect in vivo. In addition, Western blot analysis demonstrated that SM-BFRE exerted its anti-laryngeal cancer effect by activating the mitochondrial apoptotic pathway and inhibiting STAT3 and Akt/NF-κB signalling pathways. All results suggested that SM-BFRE could be considered as a potential chemotherapeutic drug for laryngeal cancer.


Asunto(s)
Apoptosis/efectos de los fármacos , Biflavonoides/farmacología , Neoplasias Laríngeas/metabolismo , Neoplasias Laríngeas/patología , FN-kappa B/metabolismo , Extractos Vegetales/farmacología , Factor de Transcripción STAT3/metabolismo , Selaginellaceae/química , Animales , Biflavonoides/química , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Femenino , Humanos , Ratones Endogámicos BALB C , Ratones Desnudos , Modelos Biológicos , Trasplante de Neoplasias , Extractos Vegetales/química , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal/efectos de los fármacos
2.
Front Pharmacol ; 8: 801, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29163181

RESUMEN

Shengfu oil is a traditional Chinese medicine formula containing 16 ingredients, including Scutellariae radix, Olibanum, and Rehmanniae radix. In this study, we aimed to enhance the wound healing of rabbit full-thickness scalded skin by Shengfu oil and to elucidate its regulatory effects on ß-catenin, Dlk1, and COX-2. We found that Shengfu oil exhibited significant anti-inflammatory, analgesic, and antimicrobial activities. The structure of wound tissues in Shengfu oil group was intact, including regenerated cutaneous appendages, indicating better healing capability of Shengfu oil compared to the controls. The protein expression of ß-catenin, Dlk1, and COX-2 in wound tissues were investigated by immunohistochemistry staining and were further quantitated with the use of multispectral imaging analysis. The protein expression of ß-catenin and Dlk1 in the Shengfu oil group was higher than that in the sesame oil group in early wound repair, accompanied by the lower expression of COX-2; the protein expression of ß-catenin decreased in the middle of wound healing; the protein expression of ß-catenin and Dlk1 increased at the end of wound healing. These results strongly suggest that Shengfu oil can enhance wound healing by regulating the expression of ß-catenin, Dlk1, and COX-2 due to its excellent anti-inflammatory, analgesic, and antimicrobial activities.

3.
Nat Struct Mol Biol ; 24(3): 205-213, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-28112729

RESUMEN

The activities of organellar ion channels are often regulated by Ca2+ and H+, which are present in high concentrations in many organelles. Here we report a structural element critical for dual Ca2+/pH regulation of TRPML1, a Ca2+-release channel crucial for endolysosomal function. TRPML1 mutations cause mucolipidosis type IV (MLIV), a severe lysosomal storage disorder characterized by neurodegeneration, mental retardation and blindness. We obtained crystal structures of the 213-residue luminal domain of human TRPML1 containing three missense MLIV-causing mutations. This domain forms a tetramer with a highly electronegative central pore formed by a novel luminal pore loop. Cysteine cross-linking and cryo-EM analyses confirmed that this architecture occurs in the full-length channel. Structure-function studies demonstrated that Ca2+ and H+ interact with the luminal pore and exert physiologically important regulation. The MLIV-causing mutations disrupt the luminal-domain structure and cause TRPML1 mislocalization. Our study reveals the structural underpinnings of TRPML1's regulation, assembly and pathogenesis.


Asunto(s)
Calcio/metabolismo , Endosomas/metabolismo , Lisosomas/metabolismo , Canales Catiónicos TRPM/química , Canales Catiónicos TRPM/metabolismo , Aminoácidos/química , Cristalografía por Rayos X , Células HEK293 , Humanos , Concentración de Iones de Hidrógeno , Modelos Moleculares , Mucolipidosis/genética , Mutación Missense , Unión Proteica , Multimerización de Proteína , Subunidades de Proteína/metabolismo , Reproducibilidad de los Resultados , Electricidad Estática , Relación Estructura-Actividad
4.
Neuron ; 82(5): 1045-57, 2014 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-24908485

RESUMEN

Neural circuitry and brain activity depend critically on proper function of voltage-gated calcium channels (VGCCs), whose activity must be tightly controlled. We show that the main body of the pore-forming α1 subunit of neuronal L-type VGCCs, Cav1.2, is proteolytically cleaved, resulting in Cav1.2 fragment channels that separate but remain on the plasma membrane. This "midchannel" proteolysis is regulated by channel activity, involves the Ca(2+)-dependent protease calpain and the ubiquitin-proteasome system, and causes attenuation and biophysical alterations of VGCC currents. Recombinant Cav1.2 fragment channels mimicking the products of midchannel proteolysis do not form active channels on their own but, when properly paired, produce currents with distinct biophysical properties. Midchannel proteolysis increases dramatically with age and can be attenuated with an L-type VGCC blocker in vivo. Midchannel proteolysis represents a novel form of homeostatic negative-feedback processing of VGCCs that could profoundly affect neuronal excitability, neurotransmission, neuroprotection, and calcium signaling in physiological and disease states.


Asunto(s)
Canales de Calcio Tipo L/metabolismo , Neuronas/metabolismo , Proteolisis , Factores de Edad , Animales , Calcio/metabolismo , Corteza Cerebral/metabolismo , Femenino , Hipocampo/metabolismo , Homeostasis , Masculino , Ratas , Xenopus
5.
Nat Commun ; 3: 1252, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23212381

RESUMEN

Polycystic kidney disease (PKD) family proteins associate with transient receptor potential (TRP) channel family proteins to form functionally important complexes. PKD proteins differ from known ion channel-forming proteins and are generally thought to act as membrane receptors. Here we find that PKD1L3, a PKD protein, functions as a channel-forming subunit in an acid-sensing heteromeric complex formed by PKD1L3 and TRPP3, a TRP channel protein. Single amino-acid mutations in the putative pore region of both proteins alter the channel's ion selectivity. The PKD1L3/TRPP3 complex in the plasma membrane of live cells contains one PKD1L3 and three TRPP3. A TRPP3 C-terminal coiled-coil domain forms a trimer in solution and in crystal, and has a crucial role in the assembly and surface expression of the PKD1L3/TRPP3 complex. These results demonstrate that PKD subunits constitute a new class of channel-forming proteins, enriching our understanding of the function of PKD proteins and PKD/TRPP complexes.


Asunto(s)
Canales Iónicos/fisiología , Sustitución de Aminoácidos/genética , Sustitución de Aminoácidos/fisiología , Animales , Canales de Calcio/genética , Canales de Calcio/fisiología , Permeabilidad de la Membrana Celular/fisiología , Dimetilaminas/metabolismo , Humanos , Canales Iónicos/química , Canales Iónicos/genética , Sustancias Macromoleculares/metabolismo , Magnesio/metabolismo , Metilaminas/metabolismo , Ratones , Estructura Terciaria de Proteína , Receptores de Superficie Celular/genética , Receptores de Superficie Celular/fisiología , Alineación de Secuencia , Xenopus
6.
J Biol Chem ; 287(27): 22749-58, 2012 Jun 29.
Artículo en Inglés | MEDLINE | ID: mdl-22589533

RESUMEN

The RGK family of monomeric GTP-binding proteins potently inhibits high voltage-activated Ca(2+) channels. The molecular mechanisms of this inhibition are largely unclear. In Xenopus oocytes, Gem suppresses the activity of P/Q-type Ca(2+) channels on the plasma membrane. This is presumed to occur through direct interactions of one or more Gem inhibitory sites and the pore-forming Ca(v)2.1 subunit in a manner dependent on the Ca(2+) channel subunit ß (Ca(v)ß). In this study we investigated the molecular determinants in Gem that are critical for this inhibition. Like other RGK proteins, Gem contains a conserved Ras-like core and extended N and C termini. A 12-amino acid fragment in the C terminus was found to be crucial for and sufficient to produce Ca(v)ß-dependent inhibition, suggesting that this region forms an inhibitory site. A three-amino acid motif in the core was also found to be critical, possibly forming another inhibitory site. Mutating either site individually did not hamper Gem inhibition, but mutating both sites together completely abolished Gem inhibition without affecting Gem protein expression level or disrupting Gem interaction with Ca(v)2.1 or Ca(v)ß. Mutating Gem residues that are crucial for interactions with previously demonstrated RGK modulators such as calmodulin, 14-3-3, and phosphatidylinositol lipids did not significantly affect Gem inhibition. These results suggest that Gem contains two candidate inhibitory sites, each capable of producing full inhibition of P/Q-type Ca(2+) channels.


Asunto(s)
Canales de Calcio Tipo N/genética , Canales de Calcio Tipo N/fisiología , Proteínas de Unión al GTP Monoméricas/genética , Proteínas de Unión al GTP Monoméricas/fisiología , Secuencias de Aminoácidos/fisiología , Secuencia de Aminoácidos , Animales , Sitios de Unión/fisiología , Canales de Calcio Tipo N/química , Calmodulina/metabolismo , Membrana Celular/fisiología , Escherichia coli/genética , Células HEK293 , Humanos , Datos de Secuencia Molecular , Proteínas de Unión al GTP Monoméricas/química , Oocitos/fisiología , Técnicas de Placa-Clamp , Mapeo Peptídico , Estructura Terciaria de Proteína/fisiología , Conejos , Ratas , Transducción de Señal/fisiología , Xenopus laevis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA